{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:59:43Z","timestamp":1784865583223,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2023-RW350-02"],"award-info":[{"award-number":["2023-RW350-02"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024CY-JJQ-47"],"award-info":[{"award-number":["2024CY-JJQ-47"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024 ZC-Y YDP-48"],"award-info":[{"award-number":["2024 ZC-Y YDP-48"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024SF-ZDCYL-03-14"],"award-info":[{"award-number":["2024SF-ZDCYL-03-14"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260865"],"award-info":[{"award-number":["82260865"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202312233"],"award-info":[{"award-number":["tsqn202312233"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neuropharm.2025.110727","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:43:22Z","timestamp":1761288202000},"page":"110727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["\u03b1-Asaronol, a low-toxicity \u03b1-asarone metabolite, suppresses seizures in zebrafish Dravet syndrome via positive modulation of GABAA receptors and LDH inhibition"],"prefix":"10.1016","volume":"283","author":[{"given":"Ying","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3489-1038","authenticated-orcid":false,"given":"Yajun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xirui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kechun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Ping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2025.110727_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054166","article-title":"Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs","volume":"8","author":"Afrikanova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110727_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111650","article-title":"Polygala tenuifolia-Acori tatarinowii herbal pair as an inspiration for substituted cinnamic \u03b1-asaronol esters: design, synthesis, anticonvulsant activity, and inhibition of lactate dehydrogenase study","volume":"183","author":"Bai","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2025.110727_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2019.112212","article-title":"The asarone-derived phenylpropanoids from the rhizome of Acorus calamus var. angustatus besser","volume":"170","author":"Bai","year":"2020","journal-title":"Phytochemistry"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110727_bib4","first-page":"759","article-title":"Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression","volume":"131","author":"Baraban","year":"2005","journal-title":"Neuroscience (Oxford, U. K.)"},{"key":"10.1016\/j.neuropharm.2025.110727_bib5","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/ncomms3410","article-title":"Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment","volume":"4","author":"Baraban","year":"2013","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110727_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/mutage\/gew007","article-title":"Comparative investigation of the mutagenicity of propenylic and allylic asarone isomers in the ames fluctuation assay","volume":"31","author":"Berg","year":"2016","journal-title":"Mutagenesis"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110727_bib7","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1021\/acschemneuro.1c00044","article-title":"Identification of potential antiseizure agents in Boswellia sacra using in vivo zebrafish and mouse epilepsy models","volume":"12","author":"Brillatz","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110727_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.fct.2015.11.021","article-title":"Metabolism of the carcinogen alpha-asarone in liver microsomes","volume":"87","author":"Cartus","year":"2016","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110727_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tiv.2005.01.007","article-title":"In vitro genotoxic evaluation of three \u03b1-asarone analogues","volume":"19","author":"Cassani-Galindo","year":"2005","journal-title":"Toxicol. Vitro"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110727_bib10","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/epi.14536","article-title":"Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood","volume":"59","author":"Chiron","year":"2018","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110727_bib11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","article-title":"De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy","volume":"68","author":"Claes","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110727_bib12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jnr.10079","article-title":"Glucose and lactate metabolism during brain activation","volume":"66","author":"Dienel","year":"2001","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110727_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.06.004","article-title":"The anticonvulsant stiripentol acts directly on the GABAA receptor as a positive allosteric modulator","volume":"56","author":"Fisher","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110727_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.766744","article-title":"Alpha-asaronol alleviates dysmyelination by enhancing glutamate transport through the activation of PPAR\u03b3-GLT-1 signalingin hypoxia-ischemia neonatal rats","volume":"13","author":"Ge","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110727_bib15","first-page":"669","article-title":"Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome","volume":"140","author":"Griffin","year":"2017","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110727_bib16","doi-asserted-by":"crossref","first-page":"fcz008","DOI":"10.1093\/braincomms\/fcz008","article-title":"Zebrafish studies identify serotonin receptors mediating antiepileptic activity in Dravet syndrome","volume":"1","author":"Griffin","year":"2019","journal-title":"Brain Commun."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110727_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/epi4.12624","article-title":"An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: a report from the Fenfluramine European early access program","volume":"7","author":"Guerrini","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.neuropharm.2025.110727_bib18","series-title":"Guidelines for Research Involving Recombinant DNA Molecules","year":"2002"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110727_bib19","first-page":"158","article-title":"Efficacy of asarone in preventing recurrent febrile seizures: a prospective clinical study of 72 cases","volume":"22","author":"Guo","year":"2010","journal-title":"Strait Pharm. J."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110727_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0278-6915(94)90194-5","article-title":"Genotoxicity of the alkenylbenzenes \u03b1- and \u03b2-asarone, myristicin and elemicin as determined by the UDS assay in cultured rat hepatocytes","volume":"32","author":"Hasheminejad","year":"1994","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110727_bib21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1039\/C6FO01701K","article-title":"In vitro genotoxicity of carcinogenic asarone isomers","volume":"8","author":"Haupenthal","year":"2017","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110727_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharep.2017.08.004","article-title":"Anticonvulsant activities of \u03b1-asaronol ((E)-3'-hydroxyasarone), an active constituent derived from \u03b1-asarone","volume":"70","author":"He","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2025.110727_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111484","article-title":"DNA double strand break repair as cellular response to genotoxic asarone isomers considering phase I metabolism","volume":"142","author":"Hermes","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110727_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/srep28248","article-title":"A novel long-term, multi-channel and non-invasive electrophysiology platform for zebrafish","volume":"6","author":"Hong","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110727_bib25","first-page":"280","article-title":"\u03b1-Asarone for febrile seizures in children: mechanistic insights and clinical outcomes","author":"Huang","year":"2007","journal-title":"Acta Med. Sinica"},{"key":"10.1016\/j.neuropharm.2025.110727_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2012.09.001","article-title":"Alpha-asarone from Acorus gramineus alleviates epilepsy by modulating A-Type GABA receptors","volume":"65","author":"Huang","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110727_bib27","first-page":"1","article-title":"Mutagenicity and in vitro metabolic pathway profiling of \u03b1-Asarone from acorus tatarinowii: a mechanistic investigation","volume":"11","author":"Jin","year":"1982","journal-title":"Journal of Zhejiang University (Medical Sciences)"},{"key":"10.1016\/j.neuropharm.2025.110727_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107760","article-title":"Involvement of peroxisome proliferator-activated receptor in anticonvulsant activity of asaronol against pentylenetetrazole-induced seizures in zebrafish","volume":"162","author":"Jin","year":"2020","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110727_bib29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1248\/yakushi.130.1325","article-title":"Pharmaceutical active metabolites of currently marketed drugs: potential resources for new drug discovery and development","volume":"130","author":"Kang","year":"2010","journal-title":"Yakugaku Zasshi"},{"issue":"21","key":"10.1016\/j.neuropharm.2025.110727_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111420","article-title":"Comparative antiseizure analysis of diverse natural coumarin derivatives in zebrafish","volume":"22","author":"Koziol","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"31","key":"10.1016\/j.neuropharm.2025.110727_bib31","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1016\/S0040-4039(00)97659-7","article-title":"1,4-Benzoquinone: a new selective reagent for oxidation of alcohols","volume":"31","author":"Kulkarni","year":"1990","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.neuropharm.2025.110727_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.110032","article-title":"Psychiatric comorbidities before and after cannabidiol treatment in adult patients with drug resistant focal epilepsy","volume":"160","author":"Lamonarca","year":"2024","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110727_bib33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110727_bib34","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/ptr.4596","article-title":"Anxiolytic-like effect of \u03b1-Asarone in mice","volume":"26","author":"Liu","year":"2012","journal-title":"Phytother Res."},{"issue":"29","key":"10.1016\/j.neuropharm.2025.110727_bib35","doi-asserted-by":"crossref","first-page":"48385","DOI":"10.18632\/oncotarget.16801","article-title":"The effects of herbal medicine on epilepsy","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110727_bib36","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1021\/acsmedchemlett.9b00063","article-title":"Do zebrafish obey lipinski rules?","volume":"10","author":"Long","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110727_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043850","article-title":"Evaluation of 14 organic solvents and carriers for screening applications in zebrafish embryos and larvae","volume":"7","author":"Maes","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110727_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2024.100187","article-title":"Toxicokinetics of a developmental toxicity test in zebrafish embryos and larvae: relationship with drug exposure in humans and other mammals","volume":"7","author":"Nawaji","year":"2024","journal-title":"Curr. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110727_bib39","first-page":"199","article-title":"A new type of anticonvulsant, stiripentol. Pharmacological profile and neurochemical study","volume":"34","author":"Poisson","year":"1984","journal-title":"Arzneim.-Forsch."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110727_bib40","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/epi.17201","article-title":"Stiripentol inhibits spike-and-wave discharges in animal models of absence seizures: a new mechanism of action involving T-type calcium channels","volume":"63","author":"Riban","year":"2022","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110727_bib41","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1021\/tx500109s","article-title":"Impact of structural and metabolic variations on the toxicity and carcinogenicity of Hydroxy- and alkoxy-substituted Allyl- and propenylbenzenes","volume":"27","author":"Rietjens","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"6228","key":"10.1016\/j.neuropharm.2025.110727_bib42","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.aaa1299","article-title":"Targeting LDH enzymes with a stiripentol analog to treat epilepsy","volume":"347","author":"Sada","year":"2015","journal-title":"Science (Washington, DC, U. S.)"},{"issue":"Part_B","key":"10.1016\/j.neuropharm.2025.110727_bib43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.fct.2018.04.025","article-title":"Formation and fate of DNA adducts of alpha- and beta-asarone in rat hepatocytes","volume":"116","author":"Stegmueller","year":"2018","journal-title":"Food Chem. Toxicol."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110727_bib44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s40263-022-00955-9","article-title":"Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies","volume":"36","author":"Strzelczyk","year":"2022","journal-title":"CNS Drugs"},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2025.110727_bib45","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yebeh.2015.05.012","article-title":"A pharmacological basis of herbal medicines for epilepsy","volume":"52","author":"Sucher","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2025.110727_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128255","article-title":"Biologically active metabolites in drug discovery","volume":"48","author":"Sun","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2025.110727_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jpba.2019.05.004","article-title":"Pharmacokinetics and tissue distribution evaluation of \u03b1-asaronol and its main metabolite in rats by HPLC method","volume":"172","author":"Sun","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110727_bib48","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s11011-017-0108-z","article-title":"Anxiolytic-like effects of \u03b1-asarone in a mouse model of chronic pain","volume":"32","author":"Tian","year":"2017","journal-title":"Metab. Brain Dis."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110727_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jnr.23688","article-title":"Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels","volume":"94","author":"Verleye","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2025.110727_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2014.00040","article-title":"Identification of both GABAA receptors and voltageactivated Na+ channels as molecular targets of anticonvulsant \u03b1-asarone","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110727_bib51","series-title":"The Zebrafish Book : a Guide for the Laboratory Use of Zebrafish (Brachydanio Rerio)","author":"Westerfield","year":"2000"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110727_bib52","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/epi.17274","article-title":"International consensus on diagnosis and management of Dravet syndrome","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110727_bib53","first-page":"2275","article-title":"Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL\/6J \u00d7 C3H\/HeJ F1 mice","volume":"47","author":"Wiseman","year":"1987","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110727_bib54","first-page":"1670","article-title":"Effect of acorus gramimeus and its active component \u03b1-asarone on N-methyl-D-asperate receptor 1 of hippocamp neurons in epileptic young rats","volume":"38","author":"Yang","year":"2007","journal-title":"Zhongcaoyao"},{"key":"10.1016\/j.neuropharm.2025.110727_bib55","first-page":"130","article-title":"Neuroprotective effect of alpha-asarone on the rats model of cerebral ischemia-reperfusion stroke via ameliorating glial activation and autophagy","volume":"473","author":"Zhang","year":"2021","journal-title":"Neuroscience (Amsterdam, Neth.)"},{"issue":"17","key":"10.1016\/j.neuropharm.2025.110727_bib56","first-page":"38","article-title":"Effects of \u03b1-asaronol, a core metabolic effector of acorus calamus, on neuronal morphology and astrocyte activation in hippocampus of epileptic young mice","volume":"61","author":"Zhao","year":"2021","journal-title":"Shandong Med. J."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110727_bib57","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1021\/acsomega.1c06922","article-title":"Revealing the antiepileptic effect of \u03b1-Asaronol on pentylenetetrazole-induced seizure rats using NMR-based metabolomics","volume":"7","author":"Zhao","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.neuropharm.2025.110727_bib58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jare.2023.11.022","article-title":"An integrated in vitro human iPSCs-derived neuron and in vivo animal approach for preclinical screening of anti-seizure compounds","volume":"64","author":"Zhao","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.neuropharm.2025.110727_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103828","article-title":"Adverse events of epidiolex: a real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database","volume":"90","author":"Zhou","year":"2023","journal-title":"Asian J. Psychiatr."},{"issue":"7712","key":"10.1016\/j.neuropharm.2025.110727_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41586-018-0255-3","article-title":"Structure of a human synaptic GABAA receptor","volume":"559","author":"Zhu","year":"2018","journal-title":"Nature (London, U. K.)"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:22:39Z","timestamp":1780820559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825004356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":60,"alternative-id":["S0028390825004356"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110727","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Asaronol, a low-toxicity \u03b1-asarone metabolite, suppresses seizures in zebrafish Dravet syndrome via positive modulation of GABAA receptors and LDH inhibition","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110727"}}